» Articles » PMID: 26908457

Identification of Long Non-coding RNAs As Novel Biomarker and Potential Therapeutic Target for Atrial Fibrillation in Old Adults

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Feb 25
PMID 26908457
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation (AF) is a highly prevalent cardiac arrhythmia disease, which widely leads to exacerbate heart failure and ischemic stroke in elder world. Recently, long non-coding RNAs (lncRNAs), a subclass of noncoding RNAs, have been reported to play critical roles in pathophysiology of cardiac heart. However, little is known of their role in cardiac arrhythmia. In the present study, we investigated the expression levels of lncRNAs of AF patients and healthy people with Agilent Human lncRNA array for the first time. 177 lncRNAs of 78243 and 153 mRNAs of 30215 tested were identified to be differentially expressed (≥ 2-fold change), indicating that the expression of many lncRNAs are upregulated or downregulated in AF. Among these, NONHSAT040387 and NONHSAT098586 were the most upregulated and downregulated lncRNAs. Real time quantitative PCR were employed to validate the microarray analysis findings, and the results confirmed the consistence. GO and KEGG pathway analysis were applied to explore the potential lncRNAs functions, some pathways including oxygen transporter activity and protein heterodimerization activity were speculated to be involved in AF pathogenesis. These results shed some light on lncRNAs' physiologic functions and provide useful information for exploring potential therapeutic treatments for heart rhythm disease.

Citing Articles

Transcriptomics, Proteomics and Bioinformatics in Atrial Fibrillation: A Descriptive Review.

Belfiori M, Lazzari L, Hezzell M, Angelini G, Dong T Bioengineering (Basel). 2025; 12(2).

PMID: 40001669 PMC: 11851880. DOI: 10.3390/bioengineering12020149.


lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction.

Pan-Lizcano R, Nunez L, Pinon P, Aldama G, Flores X, Calvino-Santos R PLoS One. 2024; 19(5):e0304041.

PMID: 38771854 PMC: 11108170. DOI: 10.1371/journal.pone.0304041.


The roles of long noncoding RNAs in atrial fibrillation.

Beylerli O, Ju J, Beilerli A, Gareev I, Shumadalova A, Ilyasova T Noncoding RNA Res. 2023; 8(4):542-549.

PMID: 37602317 PMC: 10432912. DOI: 10.1016/j.ncrna.2023.08.004.


Long non-coding RNA and circular RNA: new perspectives for molecular pathophysiology of atrial fibrillation.

da Silva A, Cruz M, Costa de Souza K, Silbiger V Mol Biol Rep. 2023; 50(3):2835-2845.

PMID: 36596997 DOI: 10.1007/s11033-022-08216-0.


Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation.

Ke X, Zhang J, Huang X, Li S, Leng M, Ye Z Front Cardiovasc Med. 2022; 9:791156.

PMID: 35141302 PMC: 8818759. DOI: 10.3389/fcvm.2022.791156.


References
1.
Zhao W, Luo J, Jiao S . Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep. 2014; 4:6591. PMC: 4194441. DOI: 10.1038/srep06591. View

2.
Liu Z, Zhou C, Liu Y, Wang S, Ye P, Miao X . The expression levels of plasma micoRNAs in atrial fibrillation patients. PLoS One. 2012; 7(9):e44906. PMC: 3445571. DOI: 10.1371/journal.pone.0044906. View

3.
Di Gesualdo F, Capaccioli S, Lulli M . A pathophysiological view of the long non-coding RNA world. Oncotarget. 2014; 5(22):10976-96. PMC: 4294373. DOI: 10.18632/oncotarget.2770. View

4.
Dewland T, Glidden D, Marcus G . Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter. PLoS One. 2014; 9(7):e100509. PMC: 4077565. DOI: 10.1371/journal.pone.0100509. View

5.
Cooley N, Cowley M, Lin R, Marasco S, Wong C, Kaye D . Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics. 2011; 44(3):211-9. DOI: 10.1152/physiolgenomics.00111.2011. View